Market Trends and Forecast: Point of Care Molecular Diagnostics for Cancer Diagnosis
Point of Care Molecular Diagnostics Market Overview The global point-of-care molecular diagnostics market size is projected to reach USD 4.1 billion by 2026 from USD 2.8 billion in 2021, at a CAGR of 8.2%. This growth is attributed to the increasing incidence of infectious diseases, rising awareness among patients and healthcare professionals, technological advancements in molecular diagnostics, and increasing adoption of point-of-care testing. Additionally, factors such as the growing geriatric population and rising demand for personalized medicine are expected to drive the market growth. However, high cost associated with molecular diagnostics and the lack of reimbursement policies in some countries are likely to hamper the growth of the market. Point of Care Molecular Diagnostics Market Trends and Drivers The Point of Care Molecular Diagnostics market is expected to witness significant growth over the forecast period. This growth can be attributed to the increasing prevalence...